Boost knowledge guided cancer therapy
Clear insight in molecular modeling of every unique mutation, fast & precise
Protyon is focused on improving the efficacy of cancer treatment
During treatment, novel cancer mutations can emerge, leading to progression of the disease and a need for new treatment
This leaves clinicians the hard task to select a suitable therapy for each different tumour from a variety of approved drugs with little information on their likely effectiveness
Our solution boosts knowledge guided cancer therapy
We provide structural biology tools directly to the clinic allowing to first test the efficacy of the drugs with digital tools in tailor-made models of the patient’s cancer-driving proteins.
1. Input mutations of the cancer driven protein
We construct a digital 3D model of the cancer drivers from the patient’s molecular fingerprint.
2. Test available treatments
We then use the molecular models to test available therapies in a computer and analyze their efficacy to delay the cancer.
3. Output Report
We provide the clinician with a ranking of the drugs most likely to efficiently treat the individual patient’s disease.
We have developed an approach to use 3D structural information on the cancer driving protein combined with computational analysis of its interaction with potential drugs. This new information for oncologists supports fast clinical decisions on a truly personalised level.